Thursday, 7 November 2013

International osteoporosis foundation working group provides guidance on fracture prevention in cancer-associated bone disease

Bones are often affected in cancer patients, frequently because of bone metastases, or as a result of anti-cancer therapies which can contribute to bone loss and fragility. A new paper published by an International Osteoporosis Foundation Committee of Scientific Advisors Working Group reviews the epidemiology and pathophysiology of cancer-associated bone disease and provides information about fracture prevention in cancer patients. The review summarises the pertinent recommendations of leading societies, providing guidance for clinical decision making and information on evidence-based pathways to prevent skeletal-related events and bone loss. Read more here.

Study mentioned: Rizzoli R, et al. Cancer-associated bone disease. Osteoporos Int. 2013 Oct 22. [Epub ahead of print] PMID: 24146095

No comments:

Post a Comment